Fund Monitors Pty Ltd

www.fundmonitors.com
© Copyright 2026
Printed: 21 September 2026 2:36 PM

7 Feb 2020 - Performance Report: Frazis Fund

By: Australian Fund Monitors
Copy Article Link

Report Date07 February 2020
ManagerFrazis Capital Partners
Fund NameFrazis Fund
StrategyEquity Long/Short
Latest Return DateDecember 2019
Latest Return-4.00%
Latest 6 Months10.82%
Latest 12 Months24.18%
Latest 24 Months (pa)
Annualised Since Inception-3.88%
Inception Date01 July 2018
FUM (millions)AU$5.3
Fund OverviewThe Frazis Fund is a thematic long/short global equity fund, with a macro overlay. The portfolio pairs high conviction, concentrated, long-term equity investments, with asymmetric, proprietary hedging strategies, to create a unique and highly differentiated return profile.

The manager follows a disciplined, process-driven, and thematic strategy focused on five core investment strategies:

1) Growth stocks that are really value stocks;
2) Traditional deep value;
3) The life sciences;
4) Miners and drillers expanding production into supply deficits;
5) Global special situations;

The manager uses a macro overlay to manage exposure, hedging in three ways:

1) Direct shorts
2) Upside exposure to the VIX index
3) Index optionality
Manager CommentsThe Frazis Fund rose +11.04% over the December 2019 quarter and ended CY2019 up +24.18%. The portfolio contracted by -4.0% in December, though more than half of this was due to currency. Frazis noted that, given the Fund's long-only portfolio finished the year up +70%, they were disappointed the Fund didn't do better.

The Fund's core holdings in Afterpay, Carvana, Pinduoduo and Pointsbet performed well over the year. Frazis noted the Fund is already starting to reap the rewards of increasing their investments in those companies this year.

The Fund is now concentrated into seven core investments: US software (Twilio, Alteryx, MongoDB, Shopify), Afterpay, Carvana, Diagnostics (Exact Sciences and Guardant Health), Pinduoduo, a small number of high growth Australian smallcaps such as Pointsbet, and life sciences (drug development, DNA synthesis, tissue regeneration and genetic science).

The Fund's average portfolio organic growth rate is tracking at over 80%. Frazis expect this to slow, however they believe it's reasonable to expect the Fund's companies to be over 50% larger on a revenue basis 12 months from now.

Frazis expect the next move in interest rates in Australia to be up, with corresponding increase in the AUD.
More Information

Australian Fund Monitors Pty Ltd
A.C.N. 122 226 724
AFSL 324476
Email: contact@fundmonitors.com
Live chat